15. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn’s

disease on chromosome 16. Nature 1996;379:821–823.

16. Cho JH. The Nod2 gene in Crohn’s disease: implications for future research into the genetics and

immunology of Crohn’s disease. Inflamm Bowel Dis 2001;7(3):271–275.

17. Műzes G, Tulassay Z, Sipos F. Interplay of autophagy and innate immunity in Crohn’s disease: a key

immunobiologic feature. World J Gastroenterol 2013;19(28):4447–4454.

18. Wallace KL, Zheng LB, Kanazawa Y, et al. Immunopathology of inflammatory bowel disease. World

J Gastroenterol 2014;20(1):6–21.

19. Gilardoni LR, Paolicchi FA, Mundo SL. Bovine paratuberculosis: a review of the advantages and

disadvantages of different diagnostic tests. Rev Argent Microbiol 2012;44(3):201–215.

20. Wagner J, Sim WH, Lee KJ, et al. Current knowledge and systematic review of viruses associated

with Crohn’s disease. Rev Med Virol 2013;23(3):145–171.

21. Cabré E, Domènech E. Impact of environmental and dietary factors on the course of inflammatory

bowel disease. World J Gastroenterol 2012;18(29):3814–3822.

22. Yantiss RK, Odze RD. Diagnostic difficulties in inflammatory bowel disease pathology.

Histopathology 2006;48(2):116–132.

23. Matsui T, Yao T, Sakurai T, et al. Clinical features and pattern of indeterminate colitis: Crohn’s

disease with ulcerative colitis-like clinical presentation. J Gastroenterol 2003;38(7):647–655.

24. Dias CC, Rodrigues PP, da Costa-Pereira A, et al. Clinical prognostic factors for disabling Crohn’s

disease: a systematic review and meta-analysis. World J Gastroenterol 2013;19(24):3866–3871.

25. Schwartz DA, Loftus EV Jr, Tremaine WJ, et al. The natural history of fistulizing Crohn’s disease in

Olmsted County, Minnesota. Gastroenterology 2002;122(4):875–880.

26. Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in Crohn’s disease: a statistical study of

615 cases. Gastroenterology 1975;68(4 Pt 1):627–635.

27. Lapidus A, Bernell O, Hellers G, et al. Clinical course of colorectal Crohn’s disease: a 35-year

follow-up study of 507 patients. Gastroenterology 1998; 114(6):1151–1160.

1310

28. Binder HJ. Mechanisms of diarrhea in inflammatory bowel diseases. Ann N Y Acad Sci

2009;1165:285–293.

29. Wenzl HH. Diarrhea in chronic inflammatory bowel diseases. Gastroenterol Clin North Am

2012;41(3):651–675.

30. Bissel AD. Localized chronic ulcerative ileitis. Ann Surg 1934;99:957–966.

31. McKee RF, Keenan RA. Perianal Crohn’s disease–is it all bad news? Dis Colon Rectum

1996;39(2):136–142.

32. Homan WP, Tang C, Thorgjarnarson B. Anal lesions complicating Crohn disease. Arch Surg

1976;111(12):1333–1335.

33. Solomon MJ. Fistulae and abscesses in symptomatic perianal Crohn’s disease. Int J Colorectal Dis

1996;11(5):222–226.

34. Isaacs KL. Upper gastrointestinal tract endoscopy in inflammatory bowel disease. Gastrointest Endosc

Clin N Am 2002;12(3):451–462, vii.

35. Wagtmans MJ, van Hogezand RA, Griffioen G, et al. Crohn’s disease of the upper gastrointestinal

tract. Neth J Med 1997;50(2):S2–S7.

36. Decker GA, Loftus EV Jr, Pasha TM, et al. Crohn’s disease of the esophagus: clinical features and

outcomes. Inflamm Bowel Dis 2001;7(2):113–119.

37. Satsangi J, Grootscholten C, Holt H, et al. Clinical patterns of familial inflammatory bowel disease.

Gut 1996;38(5):738–741.

38. Orchard TR, Thiyagaraja S, Welsh KI, et al. Clinical phenotype is related to HLA genotype in the

peripheral arthropathies of inflammatory bowel disease. Gastroenterology 2000;118(2):274–278.

39. Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in

inflammatory bowel diseases. World J Gastroenterol 2006; 12(30):4819–4831.

40. Rispo A, Musto D, Tramontano ML, et al. Surgery-induced remission of extraintestinal

manifestations in inflammatory bowel diseases. J Crohns Colitis 2013;7(10):e504–e505.

41. Kelvin FM, Oddson TA, Rice RP, et al. Double contrast barium enema in Crohn’s disease and

ulcerative colitis. AJR Am J Roentgenol 1978;131(2):207–213.

42. Dambha F, Tanner J, Carroll N. Diagnostic imaging in Crohn’s disease: what is the new gold

standard? Best Pract Res Clin Gastroenterol 2014;28(3):421–436.

43. Spinelli A, Fiorino G, Bazzi P, et al. Preoperative magnetic resonance enterography in predicting

findings and optimizing surgical approach in Crohn’s disease. J Gastrointest Surg 2014;18(1):83–90.

44. Siddiki HA1, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR

enterography and CT enterography in small-bowel Crohn’s disease. AJR Am J Roentgenol

2009;193(1):113–21.

45. Gallego Ojea JC, Echarri Piudo AI, Porta Vila A. [Crohn’s disease: the usefulness of MR

enterography in the detection of recurrence after surgery]. Radiologia 2011;53(6):552–559.

46. Vanbeckevoort D, Bielen D, Vanslembrouck R, et al. Magnetic resonance imaging of perianal

fistulas. Magn Reson Imaging Clin N Am 2014;22(1):113–123.

47. Al-Hawary M, Zimmermann EM. A new look at Crohn’s disease: novel imaging techniques. Curr

Opin Gastroenterol 2012;28(4):334–340.

48. Shyn PB. 18F-FDG positron emission tomography: potential utility in the assessment of Crohn’s

disease. Abdom Imaging 2012;37(3):377–386.

49. Leighton JA, Gralnek IM, Cohen SA, et al. Capsule endoscopy is superior to small-bowel followthrough and equivalent to ileocolonoscopy in suspected Crohn’s disease. Clin Gastroenterol Hepatol

2014;12(4):609–615.

50. Hall B, Holleran G, Costigan D, et al. Capsule endoscopy: High negative predictive value in the

long term despite a low diagnostic yield in patients with suspected Crohn’s disease. United European

Gastroenterol J 2013; 1(6):461–466.

51. Carter D, Eliakim R. Current role of endoscopy in inflammatory bowel disease diagnosis and

management. Curr Opin Gastroenterol 2014;30(4):370–377.

52. Joo M, Odze RD. Rectal sparing and skip lesions in ulcerative colitis: a comparative study of

endoscopic and histologic findings in patients who underwent proctocolectomy. Am J Surg Pathol

2010;34(5):689–696

1311

53. Kochhar R, Kochhar S. Endoscopic balloon dilation for benign gastric outlet obstruction in adults.

World J Gastrointest Endosc 2010;2(1):29–35.

54. Ferreira J, Akbari M, Gashin L, et al. Prevalence and lifetime risk of endoscopy-related

complications among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol

2013;11(10):1288–1293.

55. Vucelic B. Inflammatory bowel diseases: controversies in the use of diagnostic procedures. Dig Dis

2009;27(3):269–277.

56. Morpurgo E, Petras R, Kimberling J, et al. Characterization and clinical behavior of Crohn’s disease

initially presenting predominantly as colitis. Dis Colon Rectum 2003;46(7):918–924.

57. Mahadeva U, Martin JP, Patel NK, et al. Granulomatous ulcerative colitis: a re-appraisal of the

mucosal granuloma in the distinction of Crohn’s disease from ulcerative colitis. Histopathology

2002;41(1):50–55.

58. Kim BG, Kim YS, Kim JS, et al. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies

combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.

Dis Colon Rectum 2002;45(8):1062–1069.

59. Inoue K, Aomatsu T, Yoden A, et al. Usefulness of a novel and rapid assay system for fecal

calprotectin in pediatric patients with inflammatory bowel diseases. J Gastroenterol Hepatol

2014;29(7):1406–1412.

60. Nancey S, Boschetti G, Moussata D, et al. Neopterin is a novel reliable fecal marker as accurate as

calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel

diseases. Inflamm Bowel Dis 2013;19(5):1043–1052.

61. D’Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic

lesions in inflammatory bowel disease. Inflamm Bowel Dis 2012;18(12):2218–2224.

62. Gisbert JP, McNicholl AG, Gomollon F. Questions and answers on the role of fecal lactoferrin as a

biological marker in inflammatory bowel disease. Inflamm Bowel Dis 2009;15(11):1746–1754.

63. Abraham BP, Kane S. Fecal markers: calprotectin and lactoferrin. Gastroenterol Clin North Am

2012;41(2):483–495.

64. Weston LA, Roberts PL, Schoetz DJ, Jr., et al. Ileocolic resection for acute presentation of Crohn’s

disease of the ileum. Dis Colon Rectum 1996; 39(8):841–846.

65. Li G, Ren J, Wang G, et al. Preoperative exclusive enteral nutrition reduces the postoperative septic

complications of fistulizing Crohn’s disease. Eur J Clin Nutr 2014;68(4):441–446.

66. Caprilli R, Cesarini M, Angelucci E, et al. The long journey of salicylates in ulcerative colitis: The

past and the future. J Crohns Colitis 2009;3(3):149–156.

67. Lim WC, Hanauer S. Aminosalicylates for induction of remission or response in Crohn’s disease.

Cochrane Database Syst Rev 2010;(12):CD008870.

68. Seow CH, Benchimol EI, Griffiths AM, et al. Budesonide for induction of remission in Crohn’s

disease. Cochrane Database Syst Rev 2008;(3):CD000296.

69. Prefontaine E, Macdonald JK, Sutherland LR. Azathioprine or 6-mercaptopurine for induction of

remission in Crohn’s disease. Cochrane Database Syst Rev 2010;(6):CD000545.

70. Alfadhli AA, McDonald JW, Feagan BG. Methotrexate for induction of remission in refractory

Crohn’s disease. Cochrane Database Syst Rev 2005;(1):CD003459.

71. Lapadula G, Marchesoni A, Armuzzi A, et al. Adalimumab in the treatment of immune-mediated

diseases. Int J Immunopathol Pharmacol 2014; 27(1 suppl):33–48.

72. Scott FI, Osterman MT. Medical management of crohn disease. Clin Colon Rectal Surg

2013;26(2):67–74.

73. Kopylov U, Ben-Horin S, Zmora O, et al. Anti-tumor necrosis factor and postoperative complications

in Crohn’s disease: systematic review and meta-analysis. Inflamm Bowel Dis 2012;18(12):2404–2413.

74. Wolff BG. Resection margins in Crohn’s disease. Br J Surg 2001;88(6):771–772.

75. Bernell O, Lapidus A, Hellers G. Recurrence after colectomy in Crohn’s colitis. Dis Colon Rectum

2001;44(5):647–654.

76. Tekkis PP, Purkayastha S, Lanitis S, et al. A comparison of segmental vs subtotal/total colectomy

for colonic Crohn’s disease: a meta-analysis. Colorectal Dis 2006;8(2):82–90.

77. Scammell BE, Keighley MR. Delayed perineal wound healing after proctectomy for Crohn’s colitis.

1312

Br J Surg 1986;73(2):150–152.

78. Raab Y, Bergstrom R, Ejerblad S, et al. Factors influencing recurrence in Crohn’s disease. An

analysis of a consecutive series of 353 patients treated with primary surgery. Dis Colon Rectum

1996;39(8):918–925.

79. Cellini C, Safar B, Fleshman J. Surgical management of pyogenic complications of Crohn’s disease.

Inflamm Bowel Dis 2010;16(3):512–517.

80. Sampietro GM, Casiraghi S, Foschi D. Perforating Crohn’s disease: conservative and surgical

treatment. Dig Dis 2013;31(2):218–221.

81. Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing

Crohn’s disease. Dis Colon Rectum 2002;45(6):771–775.

82. Kawalec P, Mikrut A, Wiśniewska N, et al. Tumor necrosis factor-α antibodies (infliximab,

adalimumab and certolizumab) in Crohn’s disease: systematic review and meta-analysis. Arch Med

Sci 2013;9(5):765–779.

83. Van Assche G, Geboes K, Rutgeerts P. Medical therapy for Crohn’s disease strictures. Inflamm Bowel

Dis 2004;10(1):55–60.

84. Bettenworth D, Rieder F. Medical therapy of stricturing Crohn’s disease: what the gut can learn

from other organs - a systematic review. Fibrogenesis Tissue Repair 2014;7(1):5.

85. Govani SM, Stidham RW, Higgins PD. How early to take arms against a sea of troubles? The case

for aggressive early therapy in Crohn’s disease to prevent fibrotic intestinal strictures. J Crohns

Colitis 2013;7(11):923–927.

86. Brown CJ, Maclean AR, Cohen Z, et al. Crohn’s disease and indeterminate colitis and the ileal

pouch-anal anastomosis: outcomes and patterns of failure. Dis Colon Rectum.2005;48(8):1542–1549.

87. Yamazaki Y, Ribeiro MB, Sachar DB, et al. Malignant colorectal strictures in Crohn’s disease. Am J

Gastroenterol 1991;86(7):882–885.

88. Stienecker K, Gleichmann D, Neumayer U, et al. Long-term results of endoscopic balloon dilatation

of lower gastrointestinal tract strictures in Crohn’s disease: A prospective study. World J

Gastroenterol 2009;15(21):2623–2627.

89. Swaminath A, Lichtiger S. Dilation of colonic strictures by intralesional injection of infliximab in

patients with Crohn’s colitis. Inflamm Bowel Dis 2008;14(2):213–216.

90. Despott EJ, Gupta A, Burling D, et al. Effective dilation of small-bowel strictures by double-balloon

enteroscopy in patients with symptomatic Crohn’s disease (with video). Gastrointest Endosc

2009;70(5):1030–1036.

91. Gill RS, Kaffes AJ. Small bowel stricture characterization and outcomes of dilatation by doubleballoon enteroscopy: a single-centre experience. Therap Adv Gastroenterol 2014;7(3):108–114.

92. Hirai F, Beppu T, Takatsu N, et al. Long-term outcome of endoscopic balloon dilation for small

bowel strictures in patients with Crohn’s disease. Dig Endosc 2014;26(4):545–551.

93. Endo K, Takahashi S, Shiga H, et al. World J Short and long-term outcomes of endoscopic balloon

dilatation for Crohn’s disease strictures. World J Gastroenterol 2013;19(1):86–91.

94. Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn’s disease: a

systematic review and meta-analysis. Dis Colon Rectum 2007;50(11):1968–1986.

95. Campbell L, Ambe R, Weaver J, et al. Comparison of conventional and nonconventional

strictureplasties in Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum

2012;55(6):714–726.

96. Hesham W, Kann BR. Strictureplasty. Clin Colon Rectal Surg 2013;26(2):80–83.

97. Chen M, Shen B. Comparable Short- and Long-term Outcomes of Colonoscopic Balloon Dilation of

Crohn’s Disease and Benign Non-Crohn’s Disease Strictures. Inflamm Bowel Dis 2014;20(10):1739–

1746.

98. He X, Chen Z, Huang J, et al. Stapled side-to-side anastomosis might be better than handsewn endto-end anastomosis in ileocolic resection for Crohn’s disease: a meta-analysis. Dig Dis Sci

2014;59(7):1544–1551.

99. Simillis C, Purkayastha S, Yamamoto T, et al. A meta-analysis comparing conventional end-to-end

anastomosis vs. other anastomotic configurations after resection in Crohn’s disease. Dis Colon

Rectum 2007;50(10):1674–1687.

100. Greenstein AJ, Sachar DB, Smith H, et al. Patterns of neoplasia in Crohn’s disease and ulcerative

1313